Evaluation of Hepatocellular Carcinoma Size Using Two-dimensional and Volumetric Analysis: Effect on Liver Transplantation Eligibility

Academic Radiology

Volumn 18, Issue 12, 2011, Pages 1555-1560

  Galizia, Mauricio Stanzione ^a   Töre, Hüseyin Gürkan ^a   Chalian, Hamid ^a   Yaghmai, Vahid ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

3D; CT volumetry; Liver transplantation; MDCT; Milan criteria

Indexed keywords

IOHEXOL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; FEMALE; HUMAN; IMAGE ANALYSIS; INSTITUTIONAL REVIEW; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PATIENT SELECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THREE DIMENSIONAL IMAGING; TUMOR VOLUME; VOLUMETRY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CONE-BEAM COMPUTED TOMOGRAPHY; ELIGIBILITY DETERMINATION; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TUMOR BURDEN;

EID: 80055122467     PISSN: 10766332     EISSN: 18784046     Source Type: Journal    
DOI: 10.1016/j.acra.2011.08.011     Document Type: Article

References (32)

1. Kaseb A.O., Hanbali A., Cotant M., et al. Vascular endothelial growth factor in the management of hepatocellular carcinoma: a review of literature. Cancer 2009, 115:4895-4906.
2. Bruix J., Sherman M. Management of hepatocellular carcinoma. Hepatology 2005, 42:1208-1236.
3. Bruix J., Fuster J., Llovet J.M. Liver transplantation for hepatocellular carcinoma: Foucault pendulum versus evidence-based decision. Liver Transpl 2003, 9:700-702.
4. Mazzaferro V., Regalia E., Doci R., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. New Engl J Med 1996, 334:693-699.
5. Yao F.Y., Ferrell L., Bass N.M., et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001, 33:1394-1403.
6. Freeman R.B., Wiesner R.H., Harper A., et al. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl 2002, 8:851-858.
7. Suzuki C., Jacobsson H., Hatschek T., et al. Radiologic measurements of tumor response to treatment: practical approaches and limitations. Radiographics 2008, 28:329-344.
8. Kelsey C.R., Schefter T., Nash S.R., et al. Retrospective clinicopathologic correlation of gross tumor size of hepatocellular carcinoma: implications for stereotactic body radiotherapy. Am J Clin Oncol 2005, 28:576-580.
9. Bornemann L., Kuhnigk J.M., Dicken V., et al. Informatics in radiology (infoRAD): new tools for computer assistance in thoracic CT part 2. Therapy monitoring of pulmonary metastases. Radiographics 2005, 25:841-848.
10. Kuhnigk J.M., Dicken V., Bornemann L., et al. Morphological segmentation and partial volume analysis for volumetry of solid pulmonary lesions in thoracic CT scans. IEEE Trans Med Imaging 2006, 25:417-434.
11. Keil S., Behrendt F.F., Stanzel S., et al. Semi-automated measurement of hyperdense, hypodense and heterogeneous hepatic metastasis on standard MDCT slices. Comparison of semi-automated and manual measurement of RECIST and WHO criteria. Eur Radiol 2008, 18:2456-2465.
12. Moltz J.H., Bornemann L., Kuhnigk J.M., et al. Advanced segmentation techniques for lung nodules, liver metastases, and enlarged lymph nodes in CT scans. IEEE J Sel Top Signal Process 2009, 3:122-134.
13. Bornemann L., Dicken V., Kuhnigk J.M., et al. OncoTREAT: a software assistant for cancer therapy monitoring. Int J CARS 2007, 1:231-242.
14. Marchiano A., Calabro E., Civelli E., et al. Pulmonary nodules: volume repeatability at multidetector CT lung cancer screening. Radiology 2009, 251:919-925.
15. Bruix J., Sherman M., Llovet J.M., et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001, 35:421-430.
16. Huang J.S., Pan H.B., Chou C.P., et al. Optimizing scanning phases in detecting small (<2 cm) hepatocellular carcinoma: whole-liver dynamic study with multidetector row CT. J Comput Assist Tomogr 2008, 32:341-346.
17. Ichikawa T., Kitamura T., Nakajima H., et al. Hypervascular hepatocellular carcinoma: can double arterial phase imaging with multidetector CT improve tumor depiction in the cirrhotic liver?. AJR Am J Roentgenol 2002, 179:751-758.
18. Roayaie K., Feng S. Allocation policy for hepatocellular carcinoma in the MELD era: room for improvement?. Liver Transpl 2007, 13(11 Suppl. 2):S36-S43.
19. Weismüller T.J., Fikatas P., Schmidt J., et al. Multicentric evaluation of model for end-stage liver disease-based allocation and survival after liver transplantation in Germany-limitations of the 'sickest first'-concept. Transplant Intl 2011, 24:91-99.
20. Thuluvath P.J., Guidinger M.K., Fung J.J., et al. Liver transplantation in the United States, 1999-2008. Am J Transplant 2010, 10(4 Pt 2):1003-1019.
21. Freeman R.B., Mithoefer A., Ruthazer R., et al. Optimizing staging for hepatocellular carcinoma before liver transplantation: a retrospective analysis of the UNOS/OPTN database. Liver Transpl 2006, 12:1504-1511.
22. Pawlik T.M., Delman K.A., Vauthey J.N., et al. Tumor size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl 2005, 11:1086-1092.
23. Yao F.Y., Ferrell L., Bass N.M., et al. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl 2002, 8:765-774.
24. Botea F., Marconi M., Lutman F., et al. Radiological estimation of size in colorectal liver metastases: is it reliable? Comparison with post-resectional measurements. Updates Surg 2010, 62:21-26.
25. Mantatzis M., Kakolyris S., Amarantidis K., et al. Treatment response classification of liver metastatic disease evaluated on imaging. Are RECIST unidimensional measurements accurate?. Eur Radiol 2009, 19:1809-1816.
26. Sohaib S.A., Turner B., Hanson J.A., et al. CT assessment of tumour response to treatment: comparison of linear, cross-sectional and volumetric measures of tumour size. Br J Radiol 2000, 73:1178-1184.
27. Dubus L., Gayet M., Zappa M., et al. Comparison of semi-automated and manual methods to measure the volume of liver tumours on MDCT images. Eur Radiol 2011, 21:996-1003.
28. Jaffe C.C. Measures of response: RECIST, WHO, and new alternatives. J Clin Oncol 2006, 24:3245-3251.
29. Zimmerman M.A., Ghobrial R.M., Tong M.J., et al. Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators. Arch Surg 2008, 143:182-188.
30. Hwang S., Ahn C.S., Kim K.H., et al. Super-selection of a subgroup of hepatocellular carcinoma patients at minimal risk of recurrence for liver transplantation. J Gastrointest Surg 2011, 15:971-981.
31. Miller A.B., Hoogstraten B., Staquet M., et al. Reporting results of cancer treatment. Cancer 1981, 47:207-214.
32. Buerke B., Puesken M., Beyer F., et al. Semiautomatic lymph node segmentation in multislice computed tomography: impact of slice thickness on segmentation quality, measurement precision, and interobserver variability. Invest Radiol 2010, 45:82-88.